Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy

Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy

Abstract Background Long-acting (LA) injectable antiretroviral therapy (ART) has been found non-inferior to daily oral ART in Phase 3 trials. LA ART may address key barriers to oral ART adherence and be preferable to daily pills for some people living with HIV. To date, women have been less represen...

Full description

Bibliographic Details
Main Authors: Lorie Benning, Andrea Mantsios, Deanna Kerrigan, Jenell S. Coleman, Elizabeth Golub, Oni Blackstock, Deborah Konkle-Parker, Morgan Philbin, Anandi Sheth, Adaora A. Adimora, Mardge H. Cohen, Dominika Seidman, Joel Milam, Seble G. Kassaye, Tonya Taylor, Miranda Murray
Format: Article
Language:English
Published: BMC 2020-07-01
Series:BMC Women's Health
Subjects:
HIV
ART
Long-acting injectable
Adherence
Women
Online Access:http://link.springer.com/article/10.1186/s12905-020-01011-8

Internet

http://link.springer.com/article/10.1186/s12905-020-01011-8

Similar Items